Skip to content
sellWeak

John A. McCoy Jr. sold $2,958 of ABT

VICE PRESIDENT AND CONTROLLER at ABBOTT LABORATORIES. 27 shares at an average of $109.54, traded Sep 2, 2026, filed Sep 3, 2026.

Warning score
25
Value
$2,958
27 shares
Holdings after
24,549
-0% from before
From 52-week low
+35%
low $81.98, close $110.47
From 52-week high
-17%
high $133.53, as of Sep 2, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $3k at market
    0
  • Share of holdings sold
    Sold 0.1% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • Role exit
    The filing reports the insider leaving
    +10

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ABTOct 9, 2026 · close 99.60
Since filing Sep 3, 2026: -8.4%SPY +0.9% · excess -9.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001644207-26-000012, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026FTax withholding
Common shares without par value
-52$110.36$5,73924,57639 d ago
Sep 2, 2026SOpen-market sale
Common shares without par value
-27$109.54$2,95824,54939 d ago

Related signals

Other insiders at ABBOTT LABORATORIES and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
27Weak
ABTsell
ABBOTT LABORATORIES
Eric Shroff
Senior Vice President
$203k
1,586 shares
-5%
53Moderate
ABTsell
ABBOTT LABORATORIES
Philip P Boudreau
EVP AND CFO
$747k
5,550 shares
-10%
30Weak
ABTsell
ABBOTT LABORATORIES
Sally E. Blount
director
$337k
2,600 shares
-7%
60Notable
ABTsell 6
ABBOTT LABORATORIES
Lisa D Earnhardt
EVP AND GROUP PRESIDENT
$12M
91,367 shares
-56%
49Moderate
ABTsell 6
ABBOTT LABORATORIES
John A. McCoy Jr.
VICE PRESIDENT AND CONTROLLER
$78k
562 shares
-3%
50Moderate
ABTsell 6
ABBOTT LABORATORIES
Mary K Moreland
EXECUTIVE VICE PRESIDENT
$109k
791 shares
-1%
51Moderate
ABTsell 6
ABBOTT LABORATORIES
Louis H. Morrone
EXECUTIVE VICE PRESIDENT
$154k
1,111 shares
-2%
39Weak
ABTsell 6
ABBOTT LABORATORIES
Eric Shroff
Senior Vice President
$78k
562 shares
-2%
41Moderate
ABTsell 6
ABBOTT LABORATORIES
Andrea F Wainer
RETIRED EVP
$131k
949 shares
-1%
70Notable
ABTsell 4
ABBOTT LABORATORIES
Robert B Ford
CHAIRMAN AND CEO
$37M
285,388 shares
-56%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John A. McCoy Jr. sold $2,958 of ABT | InsiderTell